AC
ACET icon

AXQ Capital’s Adicet Bio ACET Stock Holding History

AXQ Capital’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95K Buy
+10,991
New +$86.6K 0.01% 842
2023
Q1 		– Sell
-810
Closed -$116K – 472
2022
Q4 		$116K Buy
+810
New +$202K 0.08% 298

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

AXQ Capital's ACET Position: Q2 2026 in Review

AXQ Capital opened a new position in Adicet Bio (ACET) in Q2 2026: 10,991 shares worth $95K. The stake represents 0.01% of the portfolio and ranks #842 among its holdings. This is a return to the name: AXQ Capital previously reported a position in ACET as recently as Q4 2022.

AXQ Capital first reported a position in ACET in Q4 2022 and has held it in 2 quarters since. The position peaked at $116K in Q4 2022. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • AXQ Capital held 10,991 shares of Adicet Bio worth $95K as of Q2 2026.
  • Adicet Bio was a new AXQ Capital position in Q2 2026.
  • Adicet Bio made up 0.01% of AXQ Capital's portfolio in Q2 2026, its #842 holding.
  • AXQ Capital first reported a position in Adicet Bio in Q4 2022 and has held it in 2 quarters since.
  • AXQ Capital's Adicet Bio position peaked at $116K in Q4 2022.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.